Product Information
POTASSIUM CL 20 MEQ PACKET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.1202 per EA under NDC 43386019431. Its NADAC has been published 280 times since Jan 29, 2020.
FDA first approved this application on Nov 21, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
1.5 g/1.54g
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386019431
Classification
Generic
Dosage Form
FOR SOLUTION
Route
ORAL
Effective Date
5/21/2025
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210241FDA Approved
11/21/2018
TE Code
AA
On Market Since
11/21/2018
Price Statistics
The NADAC for POTASSIUM CL 20 MEQ PACKET has been published 280 times since Jan 29, 2020, and over the history we have for it it has declined 77.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1202 per EA |
|---|---|
| All-time high | $5.9151 (Jul 15, 2020) |
| All-time low | $0.9439 (Jul 17, 2024) |
| Median price | $2.0604 |
| Average price | $2.3209 |
| Largest weekly change | -47.9% (Jul 19, 2023) |
| Weeks tracked | 280 |
| Tracking since | Jan 29, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+10.5%
5Y
-50.5%
All
-77.5%
Last surveyed Jun 4, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL 20 MEQ PACKET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL 20 MEQ PACKET, manufactured by Lupin Pharmaceuticals Inc., is $1.1202 per EA (NDC 43386019431), effective Jun 4, 2025.
How has the price of POTASSIUM CL 20 MEQ PACKET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL 20 MEQ PACKET has declined 77.5%. It has been tracked across 280 weekly CMS publications since Jan 29, 2020.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL 20 MEQ PACKET?
Since Jan 29, 2020, the NADAC for POTASSIUM CL 20 MEQ PACKET has ranged from a low of $0.9439 (Jul 17, 2024) to a high of $5.9151 (Jul 15, 2020), with a median of $2.0604 per EA.
Are there cheaper alternatives to POTASSIUM CL 20 MEQ PACKET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL 20 MEQ PACKET, is $0.6242 per EA — about 44% below POTASSIUM CL 20 MEQ PACKET.
Who manufactures POTASSIUM CL 20 MEQ PACKET?
POTASSIUM CL 20 MEQ PACKET (NDC 43386019431) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.